Beyfortus 100 mg/mL single-dose pre-filled syringe Images
Generic Name: nirsevimab
This medication has been identified as Beyfortus 100 mg/mL single-dose pre-filled syringe. It is supplied by AstraZeneca.
Beyfortus is used in the treatment of RSV Vaccination and Immunization; RSV and belongs to the drug class antiviral monoclonal antibodies. Beyfortus 100 mg/mL single-dose pre-filled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Beyfortus
- Generic Name
- nirsevimab
- Strength
- 100 mg/mL single-dose pre-filled syringe
- Availability
- Prescription only
- Drug Class
- Antiviral monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 49281-0574
See also:
More about Beyfortus (nirsevimab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral monoclonal antibodies
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.